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Summary: 
Mitral regurgitation is a frequent finding in patients with aortic stenosis scheduled for aortic 
valve replacement. Detection of mitral regurgitation in such patients has important 
implications, as it can independently affect functional status and prognosis. When mitral 
regurgitation is moderate-to-severe, a decision to operate on both valves should only be made 
following a careful clinical and echocardiographic assessment. Indeed, double-valve surgery 
increases peri- and post-operative risks, and mitral regurgitation may improve spontaneously 
after isolated aortic valve replacement. Better understanding of the determinants of these 
changes appears particularly crucial in the light of recent advances in percutaneous aortic 
valve replacement.  
 
Introduction 
At the time of aortic valve replacement (AVR), many patients with aortic stenosis (AS) 
exhibit varying degrees of mitral regurgitation (MR). The aetiology of the MR is often 
functional in nature, occurring in the absence of any significant intrinsic valvular lesion. 
Increased afterload, left ventricular (LV) remodelling, fluid overload and concomitant 
ischaemic heart dysfunction may account for the development of functional MR. When there 
is intrinsic mitral valve disease, this may result from calcification of the mitral leaflets or 
annulus, particularly in the elderly, but also from rheumatic involvement, or from 
myxomatous degeneration. MR associated with AS should not be overlooked, as it can 
worsen functional status and independently affect prognosis. Moreover, a surgeon’s decision 
to operate on both valves should only be made after careful clinical and echocardiographic 
assessment, because double-valve surgery increases the perioperative risk, and MR can 
improve spontaneously after isolated AVR. Greater awareness of the determinants of these 
changes appears particularly crucial in the light of recent advances in percutaneous AVR. In 
this article, we review current knowledge on the pathophysiology, incidence, and prognostic 
value of MR in severe AS, as well as the natural history of MR after isolated AVR.  
 
Pathophysiology 
In patients with AS, the severity of MR increases over time in relation to the increase in 
transaortic pressure gradient.[1] When MR becomes moderate to severe, it may contribute to 
the development of heart failure symptoms. Severe AS may create or worsen MR through 
several mechanisms (Figure 1). First, it increases the LV to left atrial pressure gradient, and 
thereby increases the regurgitant volume for any given effective regurgitant orifice. Secondly, 
chronic pressure overload remodels the LV, which in turn promotes mitral valve deformation. 
In addition, if severe, MR decreases forward stroke volume, thus reducing the aortic pressure 
gradient and making detection of AS more challenging (“low flow, low gradient” AS). Atrial 
fibrillation, which commonly complicates MR, may further reduce forward output and 
decrease the aortic pressure gradient. Finally, severe MR may impede the detection of 
subclinical myocardial dysfunction by preserving ejection phase indices of myocardial 
performance, such as left ventricular fractional shortening and ejection fraction.[2] 
 
Prevalence 
The cited prevalence of MR in patients undergoing AVR for AS varies among studies (Table 
1).[3-10] These studies differ markedly 1) in their inclusion and exclusion criteria, some 
including patients with organic mitral valve disease [3-5,7] and others not; 2) in the method 
for MR assessment; and 3) in the threshold of MR severity used as an end-point (Table 1). 
Some degree of MR is found in as much as 61 to 90% of patients undergoing AVR for AS. 
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More severe MR is far from exceptional. Ruel et al. reported that ≥ grade 2/4 functional MR 
was found preoperatively in 13% of 848 patients undergoing isolated AVR.[8] Barreiro et al. 
reported moderate MR in 17% of 408 patients aged ≥70 y undergoing isolated AVR.[7] In 
this population, MR was ischaemic or functional in 37%, of myxomatous origin in 34%, and 
associated with extensive valvular or subvalvular calcification in 29% of patients. Up to 74% 
of patients in a series by Waisbren et al. had moderate functional MR.[10] 
 
Prognostic value of MR in patients undergoing AVR 
The first report of simultaneous mitral and AVR was published by Cartwright and coworkers 
in 1963.[11] Severe organic MR leading to double-valve surgery is not infrequent, accounting 
for nearly 5% of all AVR.[12] Operative mortality for double-valve surgery is twice that of 
isolated AVR;[12-14] the sensitivity of the hypertrophied heart to ischaemia/reperfusion 
injury may contribute to this increased mortality. In the long-term, valve-related morbidity 
and mortality remain substantial.[14] Retrospective data reported by Gillinov et al. suggested 
that mitral valve repair during double-valve surgery might be beneficial compared to mitral 
replacement, with a long-term reduction in mortality (34% versus 46%), without increased 
peri-operative mortality.[15] Similarly, Talwar et al. reported that mitral valve repair with 
AVR provided significantly better event-free survival than double valve replacement.[16] 
When MR is less severe, and keeping in mind the good results of double valve surgery,[13] 
some groups have recommended an aggressive approach to operating on the mitral valve, 
supported by data showing that concomitant moderate to severe MR does not improve in half 
the patients, and that it even increases in a small subgroup of patients.[4,6,17] Others support 
a more conservative approach, particularly in patients with functional MR, believing that 
repair or replacement is unnecessary unless patients clearly demonstrate severe MR.[3,17-20] 
The prognostic significance of “less than severe” MR in patients undergoing isolated AVR is 
debated. Caballero-Borrego et al. reported increased perioperative morbidity (infections, 
kidney failure, and low output) and mortality in patients with preoperative MR.[9] In contrast, 
several reports have documented minimal or no impact on early morbidity when there is no 
intervention on the mitral valve.[3,17-20] Moreover, in a rather limited population undergoing 
isolated AVR (58 patients with and 58 patients without grade 2-3+ preoperative MR), Absil et 
al. found no significant impact of MR on perioperative morbidity and mortality or on mid-
term survival (mean duration of follow-up 3.2 years).[20] Ruel et al. reported that patients 
with AS and ≥ grade 2+ functional MR with left atrial diameter > 5 cm, peak aortic gradient < 
60 mm Hg or atrial fibrillation, had a higher risk of mortality, congestive heart failure, or need 
for secondary mitral valve surgery after AVR.[8] In AS, it has been shown that the increase in 
severity of MR during exercise is associated with exercise-induced symptoms.[21] Whether 
such a dynamic increase, which is of prognostic importance in patients with functional 
MR,[22,23] may influence patient outcome in AS has never been examined. However, it 
should be emphasized that exercise testing is precluded in truly symptomatic patients with 
severe AS. In such patients, dobutamine stress echocardiography is of limited value, since it 
systematically induces a significant reduction in the degree of MR.[24] 
Barreiro et al. studied 408 elderly patients undergoing isolated AVR.[7] Using multivariate 
analysis, preoperative MR was independently predictive of a higher mortality; survival was 
40% in 338 patients without or with mild preoperative MR, and 15% in the 70 patients with 
moderate MR (p=0.04). Patients with persistent or worsening MR after AVR tended to have a 
lower 5-year survival (58% versus 72%). Similar data were observed by Vanden Eynden et 
al., who found a trend towards better 10-year survival in patients with improved postoperative 
MR (p = 0.072).[25] There is thus some evidence linking perioperative MR and long-term 
prognosis. A causal relationship is, however, debatable. Moreover, the beneficial effects of 
correcting moderate MR during aortic surgery have not yet been demonstrated. 
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Does isolated AVR affect the severity of MR? 
When MR is less-than severe, decision making regarding any intervention can be difficult, 
and will be influenced by the expectation that MR may spontaneously improve, by the 
increased risk of double-valve surgery, and by the increased risk of future reoperation if 
postoperative MR remains or becomes clinically significant. Indeed, as LV cavity pressure 
drops early after surgery, the transmitral pressure gradient will decrease, resulting in an 
improvement in the MR.[26] Of note, this observation differs from the changes reported after 
acute afterload reduction induced by vasodilator therapy in heart failure patients with dynamic 
MR, in which the systolic blood pressure to left atrial pressure gradient remains unaltered.[27] 
Early improvement in MR after AVR might also be determined by an acute reverse LV 
remodelling effect, including a reduction in LV end-diastolic volume. Changes in LV shape 
and geometry may also contribute to improved MR through a decrease in mitral tethering 
forces.[28,29] Whether this mechanism occurs in the early postoperative period has been 
debated,[26] but it may become more significant in the long-term follow-up.[19] These data 
suggest that in patients with an enlarged LV, postoperative improvement in MR is related to 
both LV reverse remodelling and reduction in transmitral pressure gradient, whereas in 
patients with a small LV cavity, the decrease in pressure gradient after surgery represents the 
predominant mechanism. 
In the early postoperative period, the reduction in MR severity, as assessed by the ratio 
of the regurgitant jet to left atrial area (colour flow jet mapping), and by the regurgitant 
volume (37% and 40%, respectively) was significantly larger than the decrease in the 
effective regurgitant orifice (25%), emphasizing the determinant role of the decrease in LV to 
left atrial systolic pressure gradient.[26] The preoperative effective regurgitant orifice was 
affected to a much lesser extent than more load-dependent variables, such as colour flow 
mapping and regurgitant volume (a typical example is shown in Figure 2). This highlights the 
importance of preoperative quantification of MR with the effective regurgitant orifice, even 
though the latter parameter is not completely load independent.[30,31] Vena contracta width, 
which has been shown to be less dependent on hemodynamic variations and correlates 
reasonably well with quantitative Doppler estimates of regurgitant orifices, might be used to 
corroborate the quantitative results.[10,32] 
When preoperative MR is less-than severe and not being considered for repair or replacement 
at the time of AVR for AS (Table 2), most studies have described improved MR after surgery 
in most patients. However, conflicting reports exist regarding the exact number of patients 
with improved MR after surgery, and the magnitude of the improvement. Only 40% of 
patients had reduced MR severity in a study by Adams and Otto.[4] Brasch et al. reported that 
in a sub-group of patients with moderate-to-severe MR, 56% (9 patients) had no change in 
MR after AVR.[17] By contrast, MR improved in more than 80% of the patients in a study by 
Harris et al.[18] These discrepancies may be related to the different inclusion criteria in terms 
of MR aetiology (functional or organic) and severity, and to the timing of the postoperative 
ultrasound examination (Table 2). Importantly, only qualitative or semi-quantitative methods 
of MR evaluation have been used in most studies.[3-10,17-19,25] In addition, the majority of 
these studies were retrospective in nature. The frequent occurrence of improvement in MR 
has, however, been confirmed by more recent prospective data.[5,26] An improvement in MR 
was also reported after percutaneous transarterial AVR using the Cribier Edwards balloon-
expandable stent valve, with an MR grade decreasing from a median of 2 (moderate) to 1 
(mild) at discharge (p=0.01). In this series of high risk patients with AS, 53% of successfully 
implanted patients had moderate to severe MR at baseline, decreasing to 33% at discharge, 
and to 24% at 12 months.[33]  The presence of grade 2 MR might however, be a 
contraindication to the CoreValve ReValving System. Indeed, its LV component may 
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interfere with the mitral valve function by restricting anterior leaflet mobility or disrupting 
secondary chordae.[34] 
 
Predictive factors of postoperative MR improvement 
Several factors predictive of improvement in MR have been described (Table 2). The 
magnitude of preoperative MR itself was shown to correlate with the postoperative 
improvement in MR;[3,10,26] namely, the more severe the MR, the greater the potential for 
improvement, which is not an unexpected finding. The functional nature of MR was also 
found to be predictive of improvement. In their retrospective review, Barreiro et al. observed 
that 82% of patients with functional MR improved postoperatively, whereas in 50% with 
myxomatous MR and in 80% with calcified disease, the MR remained unchanged or 
worsened.[7] Similarly, Vanden Eynden et al. found that isolated ischaemic and functional 
MR were the only preoperative factors predictive of MR improvement after AVR.[25] In 
contrast, we did not observe greater MR improvement in the early postoperative period in 
patients with functional compared to patients with organic MR.[26] This discrepancy may be 
related to the relatively small number of patients with purely functional MR in the study by 
Barreiro,[7] and to the different time-delay for the postoperative echocardiography, reaching 
up to one year in the study by Vanden Eynden et al.[25] In addition, in line with our 
observation is a report by Kizilbach et al., which noted that aetiologic determination of MR 
did not always predict whether the regurgitant orifice is dynamic or fixed in individual 
patients.[30] The fact that reduced LV function, increase in LV size, and larger preoperative 
LV mass have also been associated with a decrease in MR [5,17,18] also supports the 
importance of the functional nature of MR in predicting post-operative improvement. 
A role of revascularization in the post-operative improvement in MR is advocated by a 
greater improvement in MR in the presence of coronary lesions compared to patients with 
functional MR but no coronary artery disease, suggesting a beneficial effect of coronary 
revascularization,[9,19] as may also be the case after coronary artery bypass grafting in 
patients with ischaemic MR without AS.[35]  
A small left atrial size predicted a lower postoperative MR in studies by Ruel et al. and 
Waisbren et al.,[8,10] but the opposite was found by Harris et al.[18] The impact of aortic 
prosthesis size, and thus of patient/prosthesis mismatch, was addressed in a study by 
Waisbren et al., who reported that there was no independent relationship of aortic prosthesis 
size with the change in MR nor with postoperative morbidity and mortality.[10] However, 
very few patients had patient/prosthesis mismatch in this series. In addition, the effective 
orifice area was derived from the manufacturer’s published values of projected in vivo 
effective orifice area, and not from the continuity equation. This issue, therefore, deserves 
further study. 
 
Postoperative increase in MR severity  
While some studies reported no increase in MR grade after surgery,[3,19] other 
authors have noted some increases in MR severity. The incidence of increasing severity of 
MR was, however, limited, occurring in 4 to 14% of patients in most studies,[4,5,7,9,17,25] 
and affecting 30% of patients in just one study.[6] Although the predictors of such an increase 
are poorly understood, the increase was generally very limited. This was confirmed by a 
quantitative approach, with the increase in effective regurgitant orifice ranging from 0.1 to 4.8 
cm² (mean 2.1 cm²) and in regurgitant volume from 1.1 to 8.1 ml (mean 3.4 ml).[26]  
 
Management of severe preoperative MR 
When MR is severe, double-valve surgery is generally considered. However, even in 
this situation, some regression may occur even if the mitral valve is not operated on. Although 
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many studies did not include any patients with severe MR,[4,7,9,10,20,25,26] there are data 
on  40 patients with severe MR who did not undergo surgical mitral valve 
intervention.[3,5,6,17-19] Interestingly, 90% of these patients had an improvement of at least 
one grade, and for the majority of them, of at least two grades. Therefore, selected patients 
with severe AS and severe MR may be considered for isolated AVR (or transcatheter aortic 
valve implantation) if the operative risk of double-valve surgery is deemed unacceptable.  
Thus, the decision to operate on both valves requires assessment of MR severity, preferably 
by the calculation of the effective regurgitant orifice, knowledge of the functional or organic 
aetiology of MR and determination of the suitability for mitral valve repair. Finally, the 
decision-making process will be influenced by the age, the presence of co-morbidities, and the 
assessment of operative risk (Figure 3). This will allow a tailored approach: Double-valve 
replacement, AVR plus mitral valve repair, isolated AVR, or transcatheter aortic valve 
implantation for patients deemed at the highest surgical risk. It is recommended that chronic 
functional ischaemic MR, when severe (that is, when the ERO is ≥20 mm²) should be 
corrected at the time of bypass surgery (European Society of Cardiology guidelines, level 
IC).[36] Because of the frequent spontaneous downgrading of MR after isolated AVR, we 
speculate that the threshold for an associated mitral procedure should be increased up to 30 
mm² when correction of severe ischaemic/functional MR is being contemplated during AVR. 
By contrast, because MR of organic origin does not improve in a substantial proportion of 
patients after isolated AVR, the conventional ERO threshold of 40 mm² [36] may be 
decreased to 30 mm², to avoid the increased risk of future reoperation on the mitral valve.   
If, after careful clinical and echocardiographic assessment, it is still unclear whether to 
operate on the mitral valve, one option may be to perform balloon dilatation of the aortic 
valve and to assess the effects of this intervention on MR; persistence of severe MR in this 




Despite an increase in peri-operative and postoperative risk after a combined procedure, 
detection of severe MR in a patient with AS requiring AVR suggests the need for a double 
valve procedure. If the operative risk of double valve surgery is deemed unacceptable, 
selected patients with associated severe MR may be considered for isolated AVR (or trans-
catheter aortic valve implantation). When feasible, mitral valve repair will be the preferred 
approach. If MR is less-than severe, spontaneous down-grading is likely to occur after 
isolated AVR, but this down-grading effect will be more pronounced for regurgitant volume 
than for the effective regurgitant orifice. A functional aetiology of MR is likely to predict 
improvement on the long-term. Because the reduction in left ventricular systolic pressure 
contributes to the decrease in regurgitant volume and to colour flow area, preoperative 
quantitative assessment of MR should be performed by measurement of the effective 
regurgitant orifice to predict postoperative MR severity.  
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Figure 1: Pathophysiology of interactions between aortic stenosis and mitral regurgitation 
(see text for details). LV, left ventricle; LA, left atrium; EF, ejection fraction 
 
Figure 2: Example of changes in mitral regurgitation induced by aortic valve replacement. 
The proximal flow-convergence region is seen preoperatively and after aortic valve 
replacement. A 32% reduction of regurgitant volume (Rvol) reduction is seen, with a lesser 
change (11%) in calculated effective regurgitant orifice (ERO). R, proximal isovelocity 
surface area radius; Alias, aliasing velocity; Max V, maximal regurgitant flow velocity; TVI, 
time velocity integral of the regurgitant jet 
 
Figure 3: Proposed decisional algorithm for management of mitral regurgitation (MR) in 
patients with aortic stenosis requiring surgery; ERO, effective regurgitant orifice; PASP, 
pulmonary artery systolic pressure; LAD, left atrial diameter; AVR, aortic valve replacement  
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Table 1: Prevalence of mitral regurgitation in patients undergoing isolated aortic valve 
replacement  
 
Authors, Year Exclusion criteria Number of 
patients 
Percentage of patients 
with preoperative MR 




None 44 61% with ≥ mild MR Colour flow mapping 
Adams  
1990 [4] 





Unstable haemodynamic state 
Arrhythmia 




Organic mitral valve disease 
Previous sternotomy or mitral 
valve surgery 
250 78% with ≥ mild MR  Colour flow mapping 
Barreiro 
2005 [7] 
Need for concomitant bypass 
surgery 
408 17.2% with ≥ moderate 
MR 
Colour flow mapping 
Ruel 
2006 [8] 
Organic mitral valve disease 
Patients who did not survive the 
operation 







Predominant coronary artery 
disease 
Type A aortic dissection 
Organic mitral valve disease 
MR secondary to SAM 
 
577 26.5% with non-severe 
MR 
Colour flow and pulsed 
wave Doppler mapping, 
pulmonary vein flow 
Waisbren 
2008 [10] 
Structural mitral valve disease 
Combined procedure (CABG) 
Endocarditis 
Right heart valve procedure 
Moderate or severe AR 
227 74% with moderate MR Vena contracta width 
 
*Among these patients, 32 had aortic balloon valvuloplasty 
MR, mitral regurgitation; AR, aortic regurgitation; CABG, coronary artery bypass grafting; 
SAM, systolic anterior motion of the mitral valve 
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who had a 
postoperative 
echo study 









factors of MR 
improvement 






N = 27 with ≥ mild 
MR 
3-388 days, 
mean 58 days 






N = 46 with ≥ mild 
MR 
1-750 days 
Mean 176 days 






Functional N=28 with ≥ mild 
MR 
2.5±4.2 months 82% Low LV fractional area  







N = 16 with ≥ 
moderate MR 








2.7 to 7.2 months 
46% at one week 
60% at late 
follow-up if ≥ 
grade II preop  








in all except 
2 patients 
N = 23 with ≥ mild 
MR on TTE 
19±10 days 
 
61% Peak velocity of tricuspid 
regurgitant jet 






Functional N = 80 with ≥ mild 
MR 












82% if functional 
35% if organic  
 




Functional N = 107 with ≥ 2+ 
MR 
18 months 44% if 2 
preoperative risk 
factor 
74% if 1 
preoperative risk 
factor 
78% if no 
preoperative risk 
factor 
No enlarged left atrium 
(>5cm) 
No low preoperative peak 
aortic pressure gradient (< 
60 mm Hg) 










N = 80 with ≥ 
moderate MR 
1 year 35% Functional (including 
ischaemic) MR 
 












72% Presence of coronary 
artery disease, absence of 
diabetes and of 
pulmonary hypertension 









N = 60 with 
no/mild MR 
N = 167 with ≥ 
moderate MR 




Trace or mild aortic 
insufficiency 
Left atrial size < 4.5cm 
Congestive heart failure 
Vena contracta 
width 
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87% decrease in 
regurgitant 
volume 
MR severity  
Mitral coaptation height 
PISA 
 
MR, mitral regurgitation; LV, left ventricle; TTE: transthoracic echocardiography; PISA, 
proximal isovelocity surface area method; CABG, coronary artery bypass grafting 
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